Cygnus deal snuffed out by Procter and Gamble:
This article was originally published in Clinica
Executive Summary
Procter & Gamble has terminated a collaboration deal with Cygnus to develop a portfolio of transdermal smoking cessation products. Cygnus says it will seek a new marketing collaboration to continue the clinical testing and commercialisation.